For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Cydex Pharmaceuticals, Inc.

USPTO Granted Patents = 54

CIPO Patents = 5

EPO Patents = 21

Trademarks = 2

Forward Citations = 505

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

James D Pipkin (26 out of 33 patents)

Gerold L Mosher (26 out of 66 patents)

Vincent D Antle (18 out of 18 patents)

4. Stephen G Machatha (13 out of 13 patents)

5. Douglas B Hecker (11 out of 11 patents)

6. Daniel Joseph Cushing (10 out of 12 patents)

7. Rupert O Zimmerer (6 out of 6 patents)

8. Rebecca L Wedel (6 out of 6 patents)

9. Karen T Johnson (6 out of 7 patents)

10. Jane A Cowee (6 out of 6 patents)

11. Diane O Thompson (5 out of 6 patents)

12. Roger A Rajewski (4 out of 23 patents)

13. Álvaro Lopes (4 out of 4 patents)

14. Daniel Monteiro (4 out of 4 patents)

15. Beau Mainous (3 out of 3 patents)

Core Competencies:

Sulfoalkyl Ether Cyclodextrin

Cyclodextrin Derivatives

Pharmaceutical Compositions

DPI Formulation

Injectable Compositions

Alkylated Cyclodextrin

Nasal Delivery

Ophthalmic Delivery

Silymarin Compositions

Clopidogrel Formulations

Latanoprost Compositions

Inhalant Formulation

54 patents: Sort by Forward Citations

1. 12698348 - Alkylated cyclodextrin compositions and processes for preparing and using the same (2026-08-04),

2. 12674005 - Alkylated cyclodextrin compositions and processes for preparing and using the same (2026-07-07),

3. 12527755 - Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin (2026-01-20),

4. 12390506 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2025-08-19),

5. 12370352 - Nasal and ophthalmic delivery of aqueous corticosteroid solutions (2025-07-29),

6. 11806402 - Sulfoalkyl ether cyclodextrin compositions (2023-11-07),

7. 11795241 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2023-10-24),

8. 11464862 - DPI formulation containing sulfoalkyl ether cyclodextrin (2022-10-11),

9. 11433082 - Composition containing sulfoalkyl ether cyclodextrin and latanoprost (2022-09-06),

10. 11382944 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2022-07-12),

11. 11208500 - Manufacturing process for cyclodextrin derivatives (2021-12-28),

12. 11020363 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-06-01),

13. 10940128 - Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-03-09),

14. 10864183 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2020-12-15),

15. 10851184 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2020-12-01),

CyDex Pharmaceuticals, Inc. is a leading pharmaceutical company specializing in the development and commercialization of novel drug delivery technologies. With a strong focus on enhancing the solubility and bioavailability of drugs, CyDex offers innovative solutions that improve patient outcomes and enable efficient drug development. Through partnerships and collaborations, CyDex strives to revolutionize drug delivery and contribute to the advancement of healthcare worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

54 Patents

#114 in San Diego, CA

#1,541 in California

#6,547 in US

#13,092 in the World

San Diego, CA, United States of America

Cydex Pharmaceuticals, Inc.

Forward Citations = 505

23 inventors:

James D Pipkin (26 out of 33 patents)

Gerold L Mosher (26 out of 66 patents)

Vincent D Antle (18 out of 18 patents)

4. Stephen G Machatha (13 out of 13 patents)

5. Douglas B Hecker (11 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…